Mental disorders are leading causes of the health-related burden globally, and in Rwanda the intergenerational mental health consequences of the 1994 Genocide against the Tutsi persist and are further compounded by poverty, such that recent studies have found 20% of the Rwandan population has one or more mental disorders. The Research Program on Children and Adversity (RPCA) has expanded its evidence-based home-visiting Sugira Muryango (SM) in Rwanda. The current study aims to assess a digitally enhanced delivery of Sugira Muryango to meet the needs of the Government of Rwanda in expanding the mental health and social services infrastructure. The proposed research will test the feasibility, acceptability and impact of a technology-enabled service delivery model using a digital tool that streamlines data collection, improves visibility of key program performance metrics, and serves as a resource for learning materials that can be used for continuous learning and training of a non-specialized workforce that is delivering an evidence-based intervention that improves caregiver mental health and family functioning. What the team learn from technology-supported delivery of Sugira Muryango - an evidence-based, trauma-informed, family-based behavioral intervention in Rwanda - can be used to improve the efficiency, effectiveness, and scalability of evidence-based mental health services in Rwanda and globally.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Risk of Harm cases time to resolution
Timeframe: Through study completion, an average of 4 months
Intervention Quality of Delivery
Timeframe: Through study completion, an average of 4 months
IZU - interventionist self-efficacy (Adapted Provider Self-efficacy scale)
Timeframe: Through study completion, an average of 4 months
John Hopkins' Dissemination and Implementation Battery (D&I)
Timeframe: Post-intervention, on average 4 months from baseline assessment.
The Implementation Leadership Scale (ILS)
Timeframe: Baseline (Pre-intervention), 4-months (Post Intervention)
Program Sustainability Assessment Tool (PSAT)
Timeframe: Baseline (Pre-intervention), 4-months (Post Intervention)
Implementation Network Metrics and Characteristics
Timeframe: Baseline (Pre-intervention), 4-months (Post Intervention)
Rwanda Demographic Health Survey- Intimate Partner Violence
Timeframe: Baseline (Pre-intervention), 4-months (Post Intervention)
Quality of Life (EQ-5D-3L)
Timeframe: Baseline (Pre-intervention), 4-months (Post Intervention)